Ph.D. Student Profile

Holly Hartman, M.S.

Holly Hartman, M.S.

  • Doctoral Candidate
  • Cognate: Biostatistics

Education

  • BS, University of Puget Sound, Mathematics and Molecular and Cellular Biology (2011)
  • MS, University of Alabama at Birmingham, Biostatistics (2016)

Research Interests & Projects

Research interests: clinical trial design, survival analysis, predictive risk modeling, health inequities, applications in oncology. 

My research has been primarily focused on clinical trial design and evaluating trials with a focus on oncology. I have developed a new trial design which is an extension of a small sample, sequential, multiple assignment, randomized trial (snSMART) that does not require any binary decision making variables. This design is more statistically efficient and ideal for rare diseases. 

I have also developed a webapp (OncCOVID: http://onccovid.med.umich.edu/) which provides personalized survival estimates for cancer patients during the pandemic to help guide the timing of their cancer care.

In my collaborative work, I have been involved in projects looking at racial disparities in prostate cancer. I have been involved with diversity, equity, and inclusion in both my research and my service and aim to continue to incorporate these ideas into my work. 

Selected Publications

*Jackson, W. C., *Hartman, H. E., Dess, R. T., Birer, S. R., Soni, P. D., Hearn, J. W., Reicherrt, Z. R., Kishan, A. U., Mahal, B. A., Zumsteg, Z. S., Efstathiou, J. A., Kaffenberger, S., Morgan, T. M., Mehra, R., Showalter, T. N., Krauss, D. A., Nguyen, P. L., Schipper, M. J., Feng, F. Y., Sandler, H. M., Hoskin, P. J., Roach, M., and Spratt, D. E., “Addition of androgendeprivation therapy or brachytherapy boost to external beam radiotherapy for men with localized prostate cancer: A network meta-analysis of randomized trials”, Journal of Clinical Oncology, Apr. 2020, Epub ahead of print. DOI: 10.1200/JCO.19.03217

*Dess, R. T., *Hartman, H. E., *Mahal, B. A., Soni, P. D., Jackson, W. C., Cooperberg, M. R., Amling, C. L., Aronson, W. J., Kane, C. J., Terris, M. K., Zumsteg, Z. S., Butler, S., Osborne, J. R., Morgan, T. M., Mehra, R., Salami, S. S., Kishan, A. U.,Wang, C., Schaeffer, E. M., Roach III, M., Pisansky, T. M., Shipley,W. U., Freedland, S. J., Sandler, H. M., Halabi, S., Feng, F. Y., Dignam, J. J., Nguyen, P. L., Schipper, M. J., andSpratt, D. E., “Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality”, JAMA Oncology, vol. 5, no. 7, pp. 975–983, May 2019. DOI: 10.1001/jamaoncol.2019.0826.

Soni, P. D., Hartman, H. E., Dess, R. T., Abugharib, A., Allen, S. G., Feng, F. Y., Zeitman, A. L., Jagsi, R., Schipper, M. J., and Spratt, D. E., “Comparison of Population-Based Observational Studies With Randomized Trials in Oncology”, Journal of Clinical Oncology, vol. 37, no. 14, pp. 1209–1216, May 2019. DOI: 10.1200/JCO.18.01074.


* indicates first authors contributed equally.